Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2025
4-1-2025 Plasmacytoma and Amyloidoma Presenting as an Iliac Mass, Zeni Kharel, Rochester Regional Health, Sungeun Kim, Rochester Regional Health, Roman M. Kowalchuk, Rochester Regional Health, et al.
3-20-2025 Unseen Hurdles in Cancer Care, Purva Shah, Rochester Regional Health and Robin M. Reid, Rochester Regional Health
2-27-2025 Elevated and Unexplained: Navigating Erythrocytosis and Thrombocytosis, Aniket-Vijay Rao, Rochester Regional Health and Peter A. Kouides, Rochester Regional Health
2-1-2025 Efficacy of PD-1 inhibitor plus chemotherapy versus chemotherapy in advanced esophageal carcinoma: A meta-analysis of phase III clinical trials, Zauraiz Anjum, Rochester Regional Health, Helai Hussaini, Shobha Mandal, et al.
2-1-2025 Efficacy of pembrolizumab in advanced esophageal carcinoma: A systematic review and meta-analysis, Helai Hussaini, Zauraiz Anjum, Rochester Regional Health, Shobha Mandal, et al.
1-16-2025 Thrombotic Microangiopathies, Ahmed Salman, Rochester Regional Health
1-1-2025 Barriers to participation in clinical trials of rural older adult cancer survivors: A qualitative study, Evelyn Arana-Chicas, Division of Medical Oncology, Rutgers Cancer Institute of NJ, Rutgers University, New Brunswick, New Jersey, USA., Laura M. Prisco, Geriatric Oncology Research Group, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., Saloni Sharma, Geriatric Oncology Research Group, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA., et al.
1-1-2025 Clinical Spectrum and Treatment Outcomes of Rare Bleeding Disorders in Female Patients: A Two-Center Experience in North Pakistan, Muhammad Usman, Nighat Shahbaz, Mehreen Ali Khan, et al.
Submissions from 2024
12-5-2024 The Whole Person: Addressing Spiritual Care in Serious Illness, Jonathan Steiner, Rochester Regional Health
12-1-2024 Detrimental Impact of Chemotherapy Dose Reduction or Discontinuation in Early Stage Triple-Negative Breast Cancer Treated With Pembrolizumab and Neoadjuvant Chemotherapy: A Multicenter Experience, Jayasree Krishnan, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Archit Patel, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., Arya Mariam Roy, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY., et al.
12-1-2024 Efficacy of trastuzumab deruxtecan in treating HER2-low breast cancer leptomeningeal metastasis: a case report, Zeni Kharel, Rochester Regional Health, Sarah Stanford, Department of Chemistry, Xavier University of Louisiana, New Orleans, LA 70125, USA., Lauryn E. Hemminger, Department of Neurology, University of Rochester Medical Center, NY 14642, USA., et al.
11-28-2024 Anaplasmosis, Zeni Kharel, Rochester Regional Health and Sungeun Kim, Rochester Regional Health
11-5-2024 Association of Palliative Care Involvement and Infectious Complications in Hospitalized Multiple Myeloma Patients - National Inpatient Database Study, Purva Shah, Rochester Regional Health, Basant Eltaher, Rochester Regional Health, Amir Mahmoud, et al.
11-5-2024 Comparing Anticoagulation Strategies in Left Ventricular Assist Devices - Direct Oral Anticoagulants, No Anticoagulation, and Warfarin: A Case Series and Systematic Review of Literature, Tripti Jain, Rochester Regional Health; Harkarandeep Singh, Rochester Regional Health; and Peter A. Kouides, Rochester Regional Health
11-5-2024 Hemophagocytic Lymphohistiocytosis in Pregnancy, a Systematic Review of Case Reports and Case Series, Ali Abdelhay, Rochester Regional Health, Basant Eltaher, Rochester Regional Health, Mouna Reghis, Rochester Regional Health, et al.
11-1-2024 Successful 13-year ongoing remission with C5 inhibitor therapy following renal transplant in atypical hemolytic uremic syndrome, Mariam A. Mostafa, Rochester Regional Health, Martin Zand, University of Rochester, Rochester, New York, USA., Jeremy Taylor, University of Rochester, Rochester, New York, USA., et al.
10-3-2024 MGUS Everywhere: What Does it Mean and What to do About it, Adam Starr, Rochester Regional Health
10-2024 P1.13A.10 Efficacy and Safety of Lurbinectedin for Small Cell Lung Cancer in a Real-World Setting: Jazz EMERGE 402 Study, Balazs Halmos, Philip Lammers, G Liu, et al.
9-26-2024 Two Sides of a Coin: Navigating Complexities of Pain Management, Tripti Jain, Rochester Regional Health and Erin Klinkman, Rochester Regional Health
9-12-2024 Palliative Care Top 5, Adam Herman, Rochester Regional Health; Michael Disalle, Rochester Regional Health; Jonathan Steiner, Rochester Regional Health; Joshua Jones, Rochester Regional Health; and James Fennelly, Rochester Regional Health
9-1-2024 Arrhythmia: Cancer in Disguise?, Zeni Kharel, Rochester Regional Health; Mohammad Talal Khan, Rochester Regional Health; and Christopher T. Sciria, Department of Medicine, Division of Cardiology, University of Rochester Medical Center, Rochester, NY.
9-2024 Changing Complete Blood Count Would Be ‘Another Hassle’ for Medicine, Ronald Sham, Rochester Regional Health
9-1-2024 Impact of anticoagulation therapy on outcomes in patients with cirrhosis and portal vein thrombosis: A large-scale retrospective cohort study, Chengu Niu, Rochester Regional Health, Jing Zhang, Rainier Springs Behavioral Health Hospital, Vancouver, WA 98686, USA., Himal Kharel, Rochester Regional Health, et al.
8-21-2024 Incessant Ventricular Tachycardia: An Atypical Presentation of Chronic Eosinophilic Leukemia, Andrew Takla, Rochester Regional Health, Purva Shah, Rochester Regional Health, Maria Sbenghe, Rochester Regional Health, et al.
8-1-2024 Generalized pustular psoriasis successfully treated with spesolimab in the setting of metastatic colon cancer, Diamond Rose Guy, University of Rochester School of Medicine and Dentistry, Rochester, New York., Sydney DeVore, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania., Vatsala Kirtani, Rochester Regional Health, et al.